PharmExec

OCTOBER 2, 2023

Kirsch discusses the complexity of the drugs and the verification process, along with EVERSANA’s new platform, ACTICS eAccess.

Insurance 115

Insurance Patients 115

PharmExec

JANUARY 6, 2023

A chat with with Indegene's Timothy Moore, Senior Vice President, Emerging Biotech and Key Accounts and Jack Mycka, Vice President, Enterprise Medical Solutions and Emerging Biotech.

Marketing 98

Marketing Medical 98

Pharmaceutical Technology

MARCH 28, 2024

In an exclusive Q&A, SaMD solutions provider Huma tells us how AI is allowing clinicians to make better decisions and why the human factor will remain a critical element of healthcare. AI is fast becoming a valuable tool for developers of regulated health apps.

Medical 59

Medical Healthcare Healthcare 59

PharmExec

OCTOBER 4, 2023

In this Q&A with Pharmaceutical Executive®, Andrew Hopkins, founder and CEO of Exscientia, reveals how artificial intelligence (AI) is currently being utilized in the pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI.

Pharma 105

Pharma Pharmaceutical 105

PharmExec

MARCH 6, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Biopharma 52

Biopharma Leads Manufacturing 52

PharmaTech

APRIL 10, 2024

In this Q&A article, industry experts discuss some of the challenges in HPAPI drug product manufacturing and the key issues sponsors should consider when partnering with a contract development and manufacturing organization (CDMO).

Manufacturing 52

Manufacturing Pharmaceutical Marketing 52

European Pharmaceutical Review

JANUARY 26, 2023

The European Medicines Agency (EMA) has published an updated Q&A document regarding ICH M10 ‘Bioanalytical Method Validation and Study Sample Analysis’. Implementation of the ICH M10 document The EU date of coming into effect of the core ICH M10 document and the corresponding Q&As was 21 January 2023.

Food and Drug Administration 94

Food and Drug Administration Medicine Pharmaceutical products Pharmaceutical 94

PharmExec

AUGUST 22, 2023

Amid Twitter's transformation into "X", social media expert Mikaela Walker weighs in on the rebrand's impact for pharma marketing, assesses ongoing brand safety risks, and highlights established social platforms and those gaining traction.

Media 90

Media Marketing Safety Management 90

PharmExec

MARCH 8, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

OCTOBER 27, 2023

Ito discusses how data-driven AI can be utilized by the pharma industry.

Pharma 111

Pharma 111

PharmExec

OCTOBER 24, 2022

Rocket Pharmaceutical's CEO and CTO spoke with Pharm Exec about adding a new position to the company's C-suite.

Pharmaceutical 85

Pharmaceutical 85

Pharmaceutical Commerce

JANUARY 22, 2024

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.

52

52

PharmExec

NOVEMBER 2, 2023

Schmidt discusses the recent announcement that Medidata and the NCI extended their partnership an additional five years.

52

52

PharmExec

JULY 17, 2023

In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.

97

97

Pharmaceutical Commerce

JUNE 14, 2023

In this latest Harvard Business School Healthcare Alumni Association Q&A, Susan Wilner Golden, DSC, lecturer at the Stanford Graduate School of Business, reveals an untapped $22 trillion global opportunity for all companies and others supporting healthy aging and longer life spans.

Healthcare 98

Healthcare Healthcare 98

Copyright Clearance Center

JUNE 6, 2023

On Wednesday, 14 June, CCC's Kevin Barrett will welcome Jamie Hullinger, solo corporate librarian of global medical technology leader Zimmer Biomet, for an informative 30-minute Q & A on navigating change and delivering value like a (solo information) pro.

Medical 98

Medical 98

PharmExec

DECEMBER 5, 2023

Jennifer Breheny Wallace, award-winning journalist and author, notes that C-Suite leaders should understand the financial risks of not taking action to address workplace burnout in 2024.

52

52

PharmExec

AUGUST 5, 2022

Court Horncastle discusses how his career led him to work with treating COPD and asthma.

111

111

PharmExec

OCTOBER 10, 2023

Klein discusses how recent FDA draft guidelines will impact the use of SaMD in the life sciences industry.

FDA 52

FDA 52

PharmExec

DECEMBER 8, 2023

Farbman discusses the struggles that pharma companies are facing when trying to raise funds and how this is impacting IPOs.

Marketing 59

Marketing Pharma 59

PharmExec

FEBRUARY 22, 2024

Kaufman discusses the ways the digital biomarkers are improving Alzheimer’s research by directly tackling some of the unique challenges that researchers face.

40

40

PharmExec

FEBRUARY 20, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Management 52

Management Healthcare Healthcare 52

PharmExec

MARCH 4, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Management 52

Management 52

PharmExec

JUNE 29, 2022

DiMambro discusses how companies can update their systems and strategies to collect data which ensures that marginalized groups and diverse voices are included.

Training 59

Training 59

PharmExec

APRIL 25, 2023

O'Neill discusses the company's place in the global market and recent advancements to improve the patient experience.

Pharmaceutical 52

Pharmaceutical Healthcare Healthcare Marketing 52

PharmExec

JUNE 13, 2022

Makar discusses the significance of AstraZeneca’s diabetes and heart failure drug Forxiga (dapagliflozin) for the treatment of chronic kidney disease (CKD).

98

98

European Pharmaceutical Review

FEBRUARY 6, 2024

Last week, the European Medicines Agency (EMA) published four new Q&As to its catalogue of Annex 1 questions. Update January 2019: This Q&A has been superseded by the Guideline on The Sterilisation of the medicinal product, active substance, excipient and primary container. What is the maximum bioburden level?

Manufacturing 52

Manufacturing Medicine Distribution Pharmaceutical 52

PharmExec

FEBRUARY 22, 2023

Pharm Exec spoke with Skalicky about new ways that life sciences companies are engaging with outsourcing.

52

52

PharmExec

NOVEMBER 29, 2023

A Q&A with Leslie Orne, CEO of Trinity Life Sciences, who discusses the latest developments in the life sciences industry and potential paths forward for companies in the space.

Healthcare 52

Healthcare Healthcare 52

PharmExec

JUNE 17, 2022

Ford discusses how rising drug costs in impact patients, and how they can either avoid them or find less-expensive options.

Patients 52

Patients 52

PharmExec

FEBRUARY 13, 2023

Pharm Exec spoke with the senior vice president and executive medical director at Amgen about how important health equity is to the entire industry.

Medical 52

Medical 52

PharmExec

JANUARY 29, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Medical 52

Medical 52

PharmExec

DECEMBER 5, 2023

Powley discusses his team’s recent patient journey mapping exercise and the impact it has had on RMMH.

Patients 52

Patients Medicine Pharmaceutical 52

PharmExec

NOVEMBER 7, 2023

Mangal discusses the causes of the shortage and how pharma companies can find solutions.

Pharma 52

Pharma 52

Clarify Health

FEBRUARY 13, 2023

Q and A with Ines Vigil, MD, MPH, MBA, FACPM, senior vice president and general manager of Provider Solutions at Clarify Health. In this Q&A, Dr. Vigil discusses why she’s so passionate about the value-based care model, why data matters so much, and the role technology plays in value-based contracts. Can you share an [.]

Physicians 52

Physicians Management 52

European Pharmaceutical Review

JULY 4, 2023

Trends in capsule formulation In this Q&A, Recipharm’s Torkel Gren discusses developments in capsule formulation, including the shift away from gelatine and the potential for growth in the inhalation capsule market. Titanium dioxide: are there alternatives?

Pharmaceutical 83

Pharmaceutical Marketing 83

PharmExec

JULY 27, 2022

Anderson speaks about his work with new technology and platforms.

52

52